Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / MED BREAKTHGH
-
Total 13F shares
-
1,289,137
-
Share change
-
-326,648
-
Total reported value
-
$43,377,551
-
Price per share
-
$33.64
-
Number of holders
-
54
-
Value change
-
-$11,112,049
-
Number of buys
-
17
-
Number of sells
-
23
Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q1 2022
As of 31 Mar 2022,
ALPS ETF TR - MED BREAKTHGH (SBIO) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,289,137 shares.
The largest 10 holders included
UBS Group AG, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, Matisse Capital, NTV Asset Management LLC, ROYAL BANK OF CANADA, Strategic Financial Services, Inc,, Beacon Pointe Advisors, LLC, and Tower Research Capital LLC (TRC).
This page lists
54
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.